Prognosis | Surgery | Treatments | Updates
High PD-L1 Levels Could Be Bad News for Mesothelioma Surgery Candidates
Yet another new study has found a link between PD-L1 levels and mesothelioma survival – this time in people slated…
-
-
Chemotherapy | Europe | International | Multi-Modality Therapy | New Studies | Research | Treatments
Induction Chemotherapy with Avastin Improves Mesothelioma Response in New Study
Mesothelioma patients who had induction chemotherapy with Avastin (bevacizumab) prior to surgery responded better than those who had only chemotherapy… -
Age is a Factor in Mesothelioma Survival After Surgery
Age appears to be one of the biggest predictors of mesothelioma survival after surgery. This holds true no matter which… -
Diagnosis | New Techniques | Prognosis | Scans | Surgery | Treatments
Mesothelioma Staging: Laparoscopy May Find Tumors PET-CT Misses
Cancer researchers at Baylor College of Medicine say diagnostic laparoscopy (DL) improves the accuracy of pleural mesothelioma staging prior to… -
Focused Radiation After Chemotherapy May Improve Mesothelioma Survival
New research suggests that mesothelioma patients who have focused radiation after chemotherapy may live longer with slower disease progression than… -
Long-Term Mesothelioma Survival: Follow-up is Critical
A newly published French case report is a reminder that long-term mesothelioma survival requires long-term follow-up. The case comes from… -
New Cancer Vaccine Might Help Resistant Mesothelioma
Researchers at Harvard are developing a new cancer vaccine. Preliminary data suggest that it might work just as well as… -
CAR T-Cell Therapy for Mesothelioma in New Phase I Trial
Researchers at Memorial Sloan Kettering in New York are about to try a new kind of CAR T-cell therapy for… -
Smartphone Monitoring System Helps Manage Mesothelioma Symptoms
A new study shows a system that connects doctors and patients via smartphone may make it easier to manage mesothelioma… -
T-Cells Test May Predict Success of New Drug Combination for Mesothelioma
A month after the FDA approved a new drug combination for pleural mesothelioma, scientists are discovering more about who might…
